Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P451: The efficacy of infliximab in tacrolomus non-responder with ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

T. Miyazaki*, N. Hida, T. Sato, M. Kawai, K. Kamikozuru, T. Takagawa, Y. Yokoyama, M. Iimuro, K. Hori, S. Nakamura

Hyogo College of Medicine, Division of Internal Medicine Department of Inflammatory Bowel Disease, Nishinomiya, Japan

P452: Safety and efficacy of infliximab biosimilar (Remsima©) in Crohn’s disease patients in clinical practice: results after 6 months of treatmentECCO '16 Amsterdam
Year: 2016
Authors:

M. F. Guerra Veloz*1, F. Argüelles Arias1, R. Perea Amarillo1, L. Castro Laria1, M. B. Maldonado Pérez1, A. Benítez Roldán1, V. Merino2, G. Ramirez2, A. Vilches Arenas3, A. Caunedo Álvarez1

1Unidad de Gestión Clínica de Aparato Digestivo Hospital Universitario Virgen Macarena, Seville, Spain, 2Unidad de Farmacia Hospital Universitario Virgen Macarena, Seville, Spain, 3Universidad de Sevilla, Medicina preventiva y salud pública, Seville, Spain

P453: Insufficient vaccination and inadequate immunisation rates amongst Korean patients with inflammatory bowel diseasesECCO '16 Amsterdam
Year: 2016
Authors:

H. H. Ryu1, H.-S. Lee2, B. D. Ye*3, N. Y. Kim4, E. J. Youn3, J. Y. Park3, E. Kang3, S. W. Hwang1, S. H. Park3, D.-H. Yang1, K.-J. Kim3, J.-S. Byeon1, S.-J. Myung1, S.-K. Yang3

1University of Ulsan College of Medicine, Asan Medical Centre, Gastroenterology, Seoul, South Korea, 2University of Ulsan College of Medicine, Asan Medical Centre, Health Screening and Promotion Centre, Seoul, South Korea, 3University of Ulsan College of Medicine, Asan Medical Centre, Gastroenterology, Inflammatory Bowel Disease Centre, Seoul, South Korea, 4University of Ulsan College of Medicine, Asan Medical Centre, Clinical Epidemiology and Biostatistics, Seoul, South Korea

P454: Combo-therapy in infliximab-resistant inflammatory bowel disease patients: data from a tertiary referral centreECCO '16 Amsterdam
Year: 2016
Authors:

S. Renna*, G. Rizzuto, E. Orlando, M. Affronti, M. Cottone, A. Orlando

‘Villa Sofia-Cervello’ Hospital, Division of Internal Medicine, Palermo, Italy

P455: The effect of concurrent HIV-1 infection on the management of patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

T. H. Ho, R. Fausel, J. Torres, J. J. Yang, T. H. Swartz, J. A. Aberg, J.-F. Colombel, S. Mehandru*

Icahn School of Medicine at Mount Sinai, New York, New York, United States

P456: Efficacy and safety of TNF antagonist for the treatment of internal fistulising Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A. Huguet1, A.-L. Mallet1, V. Desfourneaux1, L. Siproudhis1, J.-F. Bretagne2, G. Bouguen*2

1Université Rennes 1 & CHU Pontchaillou Rennes, Service de chirurgie digestive, Rennes, France, 2Université Rennes 1 & CHU Pontchaillou Rennes, Service des Maladies de l’Appareil Digestif, Rennes, France

P457: Complications and disease recurrence after primary ileocecal resection in paediatric Crohn’s disease: a multicentre cohort analysisECCO '16 Amsterdam
Year: 2016
Authors:

K. Diederen*1, L. de Ridder2, P. van Rheenen3, V. Wolters4, L. Mearin5, G. Damen6, T. de Meij7, H. van Wering8, L. Tseng1, M. Oomen9, J. de Jong9, M. Benninga1, A. Kindermann1

1Academic Medical Centre, Department of Paediatric Gastroenterology and Nutrition, Amsterdam, Netherlands, 2Erasmus MC-Sophia Children’s Hospital, Department of Paediatric Gastroenterology, Rotterdam, Netherlands, 3University Medical Centre Groningen, Department of Paediatric Gastroenterology, Groningen, Netherlands, 4University Medical Centre Utrecht, Department of Paediatric Gastroenterology, Utrecht, Netherlands, 5Leids Universitair Medisch Centrum, Department of Paediatrics, Leiden, Netherlands, 6Radboud University Medical Centre, Department of Paediatric Gastroenterology, Nijmegen, Netherlands, 7VU University Medical Centre, Department of Paediatric Gastroenterology, Amsterdam, Netherlands, 8Amphia Hospital, Department of Paediatrics, Breda, Netherlands, 9Academic Medical Centre, Department of Paediatric Surgery, Amsterdam, Netherlands

P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD auditECCO '16 Amsterdam
Year: 2016
Authors:

A. St. Clair Jones*1, S. Murray2

1Brighton and Sussex University Hospitals NHS Trust, Pharmacy, Brighton, United Kingdom, 2Royal College of Physicians, Clinical Effectiveness and Evaluation Unit, London, United Kingdom

P459: Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remissionECCO '16 Amsterdam
Year: 2016
Authors:

M. Iborra*1, B. Navarro1, X. Cortes2, M. Boscá3, T. Blazquez1, J. Herreras1, G. Trejo3, B. Beltrán1, P. Nos1

1Hospital Universitari i Politecnic La Fe, Gastroenterology, Valencia, Spain, 2Hospital de Sagunto, Gastroenterology, Sagunto, Spain, 3Hospital Clínic Valencia, Gastroenterology, Valencia, Spain

P460: Effect of fertility treatment on inflammatory bowel disease outcomesECCO '16 Amsterdam
Year: 2016
Authors:

M. Bejaoui*, C. Landman, J. Kirchgesner, A. Bourrier, I. Nion-Larmurier, H. Sokol, L. Beaugerie, J. Cosnes, P. Seksik

Saint Antoine Hospital, Gastroenterology & Nutrition, Paris, France

P461: Clinical benefit of adalimumab after surgery in the treatment of complex perianal Crohn’s disease: a tertiary referral centre experienceECCO '16 Amsterdam
Year: 2016
Authors:

G. Solina*1, S. Renna2, E. Orlando2, M. Affronti2, M. Cottone2, A. Orlando2

1’Villa Sofia-V. Cervello’ Hospital, Division of Surgery, Palermo, Italy, 2’Villa Sofia-Cervello’ Hospital, Division of Internal Medicine, Palermo, Italy

P462: Adalimumab improves treatment satisfaction with medication and work productivity amongst patients with ulcerative colitis in a clinical practice setting: results from INSPIRADAECCO '16 Amsterdam
Year: 2016
Authors:

S. Travis*1, B. Feagan2, L. Peyrin-Biroulet3, R. Panaccione4, S. Danese5, A. Lazar6, A. Robinson7, J. Petersson7, M. Bereswill6, M. Skup7, N. Chen7, S. Wang7, R. Thakkar7, J. Chao7

1Oxford University Hospitals, Oxford, United Kingdom, 2Robarts Research Institute, Ontario, Canada, 3University Hospital of Nancy, Les Nancy, France, 4University of Calgary, Medicine, Calgary, Canada, 5Istituto Clinico Humanitas, Milan, Italy, 6AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany, 7AbbVie Inc, North Chicago, Illinois, United States

P463: Combination therapy of fresh faecal microbial transplantation and antibiotics for ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

D. Ishikawa*, T. Osada, K. Haga, T. Kodani, T. Shibuya, S. Watanabe

Juntendo University, Department of Gastroenterology, Tokyo, Japan

P464: Assessing medication adherence in patients with inflammatory bowel disease: what do we choose, self-adherence scales or pharmacy rates?ECCO '16 Amsterdam
Year: 2016
Authors:

M. L. De Castro*1, L. Sanromán1, A. Martín2, N. Martínez2, M. Figueira1, V. Hernández1, J. R. Pineda1, J. Martínez-Cadilla1, S. Pereira1, V. Del Campo3, J.-I. Rodríguez-Prada1

1Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo. CHUVI, Gastroenterology, Vigo, Spain, 2Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo. CHUVI, Hospital Pharmacy, Vigo, Spain, 3Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo. CHUVI, Epidemiology, Vigo, Spain

P465: Indication-specific feasibility assessment of a placebo-controlled randomised mesalazine withdrawal study for paediatric patients with ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

N. Croft1, W. Faubion2, D. Tierens3, J. Dewulf3, D. Bwirire3, D. Stefani-Hunyady4, F. Cataldi*5

1Blizard Institute, Barts and The London School of Medicine and Dentistry, Centre for Immunobiology, London, United Kingdom, 2Mayo Clinic, Department of Gastroenterology and Hepatology, Rochester, Minnesota, United States, 3Shire, Brussels, Belgium, 4Shire, Lexington, Massachusetts, United States, 5Shire, Gastroenterology, Lexington, Massachusetts, United States

P466: Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumour necrosis factor alpha therapy: a prospective single-centre open-label studyECCO '16 Amsterdam
Year: 2016
Authors:

T. Hlavaty*, A. Krajcovicova, J. Letkovsky, I. Sturdik, T. Koller, J. Toth, M. Huorka

Comenius University, Faculty of Medicine and University Hospital Bratislava, Fifth Department of Internal Medicine, Bratislava, Slovakia

P467: The validation of the Crohn’s and Ulcerative Colitis Questionnaire–12 Plus (CUCQ-12 plus): a short quality-of-life measure for inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

S. Shwana*1, L. Alrubaiy1, H. Hutchings2, J. Williams2, A. Protheroe3, K. Mortier4

1Prince Charles Hospital, Gastroenterology, Merthyr Tydfil, United Kingdom, 2College of Medicine, Swansea University, Swansea, United Kingdom, 3Royal College of Physicians,, London, United Kingdom, 4Royal College of Physicians, London, United Arab Emirates

P468: Long-term efficacy and safety of thiopurine in biologic-naïve Japanese patients with ulcerative colitis: a multicentre retrospective studyECCO '16 Amsterdam
Year: 2016
Authors:

T. Takagi*1, M. Matsuura2, S. Yamada2, S. Bamba3, Y. Hotta1, K. Uchiyama1, Y. Naito1, H. Nakase2, A. Andoh3, T. Kawamura4, S. Katsushima5, T. Kusaka6, H. Obata7, T. Kogawa8

1Kyoto Prefectural University of Medicine, Molecular Gastroenterology and Hepatology, Kyoto, Japan, 2Kyoto University Hospital, Department of Gastroenterology and Hepatology, Kyoto, Japan, 3Shiga University of Medical Science, Department of Medicine, Otsu, Japan, 4Kyoto Second Red Cross Hospital, Kyoto, Japan, 5National Hospital Organisation Kyoto Medical Centre, Kyoto, Japan, 6Kyoto Katsura Hospital, Kyoto, Japan, 7Obata Medical Clinic, Kyoto, Japan, 8Kogawa Internal Medicine Clinic, Internal Medicine Clinic, Kyoto, Japan

P469: Changes in peripheral blood lymphocyte subsets induced by azathioprine in Crohn’s disease patientsECCO '16 Amsterdam
Year: 2016
Authors:

A. Labidi*, M. Fekih, N. Ben Mustapha, S. Ben Amor, M. Serghini, L. Kallel, J. Boubaker, A. Filali

La Rabta University Hospital, Gastroenterology, Tunis, Tunisia

P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

P. Pavlidis*, G. Chung- Faye, P. Dubois, I. Bjarnason, B. H. Hayee

King’s College Hospital, Department of Gastroenterology, London, United Kingdom